Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2011 | 06-2010 | 06-2009 | 06-2008 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 100,710 | 152,303 | 84,615 | 47,845 | -34,962 |
| Depreciation Amortization | 7,219 | 7,084 | 9,449 | 8,781 | 7,544 |
| Income taxes - deferred | 53,156 | -28,050 | 0 | N/A | N/A |
| Accounts receivable | -14,918 | -21,660 | -19,901 | -21,060 | -15,933 |
| Accounts payable and accrued liabilities | 287 | -5,307 | -10,707 | 9,121 | 3,959 |
| Other Working Capital | -14,543 | -27,399 | -54,143 | 16,858 | -11,175 |
| Other Operating Activity | -1,081 | 78,115 | 74,729 | 42,191 | 24,716 |
| Operating Cash Flow | $130,830 | $155,086 | $84,042 | $103,736 | $-25,851 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,792 | -7,895 | -7,525 | -13,675 | -11,400 |
| Net Acquisitions | -79,417 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -425,153 | -477,558 | -308,566 | -191,701 | -197,841 |
| Sale Of Investment | 456,072 | 408,585 | 111,849 | 174,420 | 162,480 |
| Purchase Sale Intangibles | -2,000 | 300 | 0 | N/A | N/A |
| Other Investing Activity | -2,100 | 200 | -2,100 | -349 | 20 |
| Investing Cash Flow | $-54,390 | $-76,668 | $-206,342 | $-31,305 | $-46,741 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 25,060 | 22,305 | 84,209 | 21,871 | 117,451 |
| Common Stock Repurchased | -200,490 | -71,393 | 0 | N/A | N/A |
| Other Financing Activity | 58,831 | 0 | -136,133 | 0 | 0 |
| Financing Cash Flow | $-116,599 | $-49,088 | $-51,924 | $21,871 | $117,451 |
| Beginning Cash Position | 92,840 | 63,510 | 237,734 | 143,432 | 98,573 |
| End Cash Position | 52,681 | 92,840 | 63,510 | 237,734 | 143,432 |
| Net Cash Flow | $-40,159 | $29,330 | $-174,224 | $94,302 | $44,859 |
| Free Cash Flow | |||||
| Operating Cash Flow | 130,830 | 155,086 | 84,042 | 103,736 | -25,851 |
| Capital Expenditure | -3,792 | -7,895 | -7,525 | -13,675 | -11,400 |
| Free Cash Flow | 127,038 | 147,191 | 76,517 | 90,061 | -37,251 |